Kos Niaspan below-statin pricing planned for pending cholesterol therapy.
Executive Summary
KOS NIASPAN TO CHALLENGE LIPID MARKET WITH BELOW STATIN PRICING: between $1.14 and $1.36 per day at retail, Kos President Daniel Bell declared at a Dillon Read meeting on generic drugs and drug delivery systems in New York April 30. "We believe Niaspan could be extraordinarily attractive to the managed care universe as the preferred starter therapy for patients newly diagnosed who require lipid medication," Bell contended. Merck's Zocor (simvastatin) lists for $1.78 per day at average wholesale prices, according to First DataBank.